Modulation of All-trans Retinoic Acid-induced MiRNA Expression in Neoplastic Cell Lines: a Systematic Review

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2019 Sep 1

PMID 31470825

Citations 11

Authors

Lara Lima

Thaisa Cristina Tavares de Melo

Diego Marques

Jessica Nayara Goes de Araujo

Isabela Samaria Fernandes Leite

Camila Xavier Alves

Julieta Genre

Vivian Nogueira Silbiger

Affiliations

Soon will be listed here.

Abstract

Background: Cancer is a genetic and epigenetic disease that involves inactivation of tumor suppressor genes and activation of proto-oncogenes. All-trans retinoic acid (ATRA) is an isomer of retinoic acid involved in the onset of differentiation and apoptosis of a number of normal and cancer cells, functioning as an anti-cancer agent in several neoplasms. Ectopic changes in the expression of certain microRNAs (miRNAs) occur in response to ATRA, leading to phenotypic alterations in neoplastic cell lines. Moreover, the modulation of miRNA patterns upon ATRA-treatment may represent an effective chemopreventive and anti-cancer therapy strategy. The present systematic review was performed to provide an overview of the modulation of ATRA-induced miRNA expression in different types of neoplastic cells and identify the efficacy of intervention factors (i.e., concentration and duration of treatment) and how they influence expression profiles of oncogenesis-targeting miRNAs.

Methods: A systematic search was conducted according to the PRISMA statement via the US National Library of Medicine MEDLINE/PubMed bibliographic search engine.

Results: The search identified 31 experimental studies involving human cell lines from nine different cancer types (neuroblastoma, acute myeloid leukemia, breast cancer, lung cancer, pancreatic cancer, glioma, glioblastoma, embryonal carcinoma, and colorectal cancer) treated with ATRA at concentrations ranging from 10 μmol/L to 10 μmol mol/L for 24 h to 21 days.

Conclusion: The concentrations used and the duration of treatment of cancer cells with ATRA varied widely. The presence of ATRA in the culture medium of cancer cells was able to modulate the expression of more than 300 miRNAs, and inhibit invasive behavior and deregulated growth of cancer cells, resulting in total tumor remission in some cases. ATRA may thus be broadly effective for neoplasm treatment and prevention, although these studies may not accurately represent in vivo conditions. Additional studies are required to elucidate ATRA-induced miRNA modulation during neoplasm treatment.

Citing Articles

miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.

Cheng Y, Fan Z, Liang C, Peng C, Li Y, Wang L Technol Cancer Res Treat. 2024; 23:15330338241248576.

PMID: 38693824 PMC: 11067685. DOI: 10.1177/15330338241248576.

Chemoprevention of neuroblastoma: progress and promise beyond uncertainties.

Aravindan N, Natarajan M, Somasundaram D, Aravindan S J Cancer Metastasis Treat. 2024; 9.

PMID: 38249515 PMC: 10798790. DOI: 10.20517/2394-4722.2022.40.

Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed.

Ceci A, Conte R, Didio A, Landi A, Ruggieri L, Giannuzzi V Front Med (Lausanne). 2023; 10:1113460.

PMID: 37521350 PMC: 10377668. DOI: 10.3389/fmed.2023.1113460.

Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Sabo A, Dudau M, Constantin G, Pop T, Geilfus C, Naccarati A Front Pharmacol. 2021; 12:652074.

PMID: 34295245 PMC: 8290364. DOI: 10.3389/fphar.2021.652074.

Histopathological prognosis of papillary thyroid carcinoma associated with nutritional status of vitamins A and E.

Lima-Antoine L, de Sousa Alves Neri J, de Melo T, Leite I, da Costa Santos D, Goes de Araujo J Eur J Clin Nutr. 2021; 76(3):469-476.

PMID: 34230633 DOI: 10.1038/s41430-021-00976-5.

References

Calin G, Croce C . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. DOI: 10.1038/nrc1997. View

Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A . MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007; 26(28):4148-57. DOI: 10.1038/sj.onc.1210186. View

Chen Y, Stallings R . Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007; 67(3):976-83. DOI: 10.1158/0008-5472.CAN-06-3667. View

Laneve P, Di Marcotullio L, Gioia U, Fiori M, Ferretti E, Gulino A . The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci U S A. 2007; 104(19):7957-62. PMC: 1876554. DOI: 10.1073/pnas.0700071104. View

Yu S, Chen H, Chang G, Chen C, Chen H, Singh S . MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57. DOI: 10.1016/j.ccr.2007.12.008. View

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

De Marchis M, Ballarino M, Salvatori B, Puzzolo M, Bozzoni I, Fatica A . A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia. 2009; 23(5):856-62. DOI: 10.1038/leu.2008.372. View

Xia H, He T, Liu C, Cui Y, Song P, Jin X . MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem. 2009; 23(4-6):347-58. DOI: 10.1159/000218181. View

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

10.

Le M, Xie H, Zhou B, Chia P, Rizk P, Um M . MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol. 2009; 29(19):5290-305. PMC: 2747988. DOI: 10.1128/MCB.01694-08. View

11.

Beveridge N, Tooney P, Carroll A, Tran N, Cairns M . Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell Signal. 2009; 21(12):1837-45. DOI: 10.1016/j.cellsig.2009.07.019. View

12.

Evangelisti C, Florian M, Massimi I, Dominici C, Giannini G, Galardi S . MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J. 2009; 23(12):4276-87. DOI: 10.1096/fj.09-134965. View

13.

Weiss F, Marques I, Woltering J, Vlecken D, Aghdassi A, Partecke L . Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology. 2009; 137(6):2136-45.e1-7. DOI: 10.1053/j.gastro.2009.08.065. View

14.

Thun M, DeLancey J, Center M, Jemal A, Ward E . The global burden of cancer: priorities for prevention. Carcinogenesis. 2009; 31(1):100-10. PMC: 2802672. DOI: 10.1093/carcin/bgp263. View

15.

Khew-Goodall Y, Goodall G . Myc-modulated miR-9 makes more metastases. Nat Cell Biol. 2010; 12(3):209-11. DOI: 10.1038/ncb0310-209. View

16.

Chen H, Shalom-Feuerstein R, Riley J, Zhang S, Tucci P, Agostini M . miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem Biophys Res Commun. 2010; 394(4):921-7. DOI: 10.1016/j.bbrc.2010.03.076. View

17.

Ragusa M, Majorana A, Banelli B, Barbagallo D, Statello L, Casciano I . MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis. J Mol Med (Berl). 2010; 88(10):1041-53. DOI: 10.1007/s00109-010-0643-0. View

18.

Das S, Foley N, Bryan K, Watters K, Bray I, Murphy D . MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res. 2010; 70(20):7874-81. PMC: 2955783. DOI: 10.1158/0008-5472.CAN-10-1534. View

19.

Meseguer S, Mudduluru G, Escamilla J, Allgayer H, Barettino D . MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J Biol Chem. 2010; 286(6):4150-64. PMC: 3039334. DOI: 10.1074/jbc.M110.167817. View

20.

Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, Paroni G . Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem. 2010; 286(5):4027-42. PMC: 3030403. DOI: 10.1074/jbc.M110.184994. View